Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

Platelet Reactivity High in Most Patients Who Develop Stent Thrombosis

L.A. McKeown

December 20, 2017

News Daily News

Radial Access Best for PCI Following Thrombolysis in STEMI

Michael O'Riordan

November 27, 2017

News Daily News

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Michael O'Riordan

October 11, 2017

News Daily News

Bleeding and Ischemic Events Fluctuate Out to 1 Year Post-STEMI: HORIZONS-AMI

Yael L. Maxwell

October 03, 2017

News Daily News

Acute MI Patients With Cancer History Less Likely to Get Evidence-Based Therapies

L.A. McKeown

September 25, 2017

News Daily News

New Performance and Quality Metrics for STEMI and NSTEMI Care

Michael O'Riordan

September 21, 2017

News Daily News

Extended Low-Dose Ticagrelor May Prevent Adverse Events Post-MI, Study Finds

Yael L. Maxwell

September 12, 2017

News Daily News

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

Michael O'Riordan

August 04, 2017

News Daily News

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

L.A. McKeown

May 23, 2017

News Daily News

More Excess Bleeding and No Benefit With Triple Therapy After PCI, Meta-analysis Finds

Todd Neale

May 05, 2017

News Daily News

ICTUS: No Benefit at 10 Years With Early Invasive Strategy in NSTE ACS Patients

Michael O'Riordan

April 11, 2017

News Daily News

The Long and Short of It: DAPT Duration Choice After Stenting Gets Help From New Score

Todd Neale

March 10, 2017

News Daily News

Faster Primary PCIs Linked to Higher Stent Thrombosis Risk With Bivalirudin

Todd Neale

March 07, 2017

News Daily News

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

Michael O'Riordan

January 18, 2017

News Daily News

Ticagrelor More Effective Than Clopidogrel in ACS-With No Extra Bleeding

Kim Dalton

August 30, 2009

Advertisement

Platelet Reactivity High in Most Patients Who Develop Stent Thrombosis

Radial Access Best for PCI Following Thrombolysis in STEMI

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Bleeding and Ischemic Events Fluctuate Out to 1 Year Post-STEMI: HORIZONS-AMI

Acute MI Patients With Cancer History Less Likely to Get Evidence-Based Therapies

New Performance and Quality Metrics for STEMI and NSTEMI Care

Extended Low-Dose Ticagrelor May Prevent Adverse Events Post-MI, Study Finds

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

More Excess Bleeding and No Benefit With Triple Therapy After PCI, Meta-analysis Finds

ICTUS: No Benefit at 10 Years With Early Invasive Strategy in NSTE ACS Patients

The Long and Short of It: DAPT Duration Choice After Stenting Gets Help From New Score

Faster Primary PCIs Linked to Higher Stent Thrombosis Risk With Bivalirudin

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

Ticagrelor More Effective Than Clopidogrel in ACS-With No Extra Bleeding

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content